Index Banner
LUX CAPITAL
The Lux Bio + Tech Index

LUXBT

$LUXBT

Index Performance

+7.74%
LUXBT
+0.23%
IBB
+10.41%
SPY

Overview

Description

Developed by Lux Capital, the Lux Bio + Tech Index™ is a secular investment theme that covers companies innovating to further the molecular understanding of the "omics stack" to companies building "operating systems" for the future of drug discovery and ultimately even drug development. Over time these companies have transformed from radical, even heretical, ideas to undeniable technical, scientific, and clinical proof points. The last decade has ushered in an unparalleled understanding of the molecular basis of biology, enabled by emergent tool kits to engineer and perturb biology, ultimately increasing the velocity of discovery. Today, Moore's Law-like cost curves exist along many axes in biotech and have given rise to an era of precise, high fidelity, large scale, highly reproducible, and increasingly automated biological and chemical experimentation and discovery. The modern scientist-entrepreneur not only sits at the wetbench but also has proficiency to deconvolute high dimensional and historically unmanageable data with GPUs, the cloud, and the array of advances from machine learning and deep learning.

Full methodology
  • TickerLUXBT
  • Inception Date04/23/2021
  • WeightingCustom
  • # of holdings53
What's inside?

Holdings

All holdings as of March 28, 2024
CSV download
BridgeBio Pharma, Inc. (BBIO)7.07%$5.70B-88.02%29.70%846.17
Janux Therapeutics, Inc. (JANX)6.01%$1.95B-6.14%75.81%18.91
Nkarta, Inc. (NKTX)5.48%$534.19MN/AN/AN/A
Sana Biotechnology, Inc. (SANA)4.43%$2.20BN/AN/AN/A
Dyne Therapeutics, Inc. (DYN)4.19%$2.30BN/AN/AN/A
Nuvalent, Inc. (NUVL)3.84%$4.40BN/AN/AN/A
Nuvation Bio, Inc. (NUVB)3.80%$793.69MN/AN/AN/A
Third Harmonic Bio, Inc. (THRD)3.50%$384.34MN/AN/AN/A
Recursion Pharmaceuticals, Inc. (RXRX)3.01%$2.08B11.88%-14.61%38.26
Schrödinger, Inc. (SDGR)2.59%$1.70B19.73%64.66%10.82
Nurix Therapeutics, Inc. (NRIX)2.53%$718.74M99.31%82.26%1.05
Fate Therapeutics, Inc. (FATE)2.40%$728.40M-34.03%71.22%2.46
ATAI Life Sciences NV (ATAI)2.24%$327.04M34.76%N/A206.75
CRISPR Therapeutics AG (CRSP)2.22%$5.74B30,885.48%59.57%9.44
Stoke Therapeutics, Inc. (STOK)2.07%$625.10M-29.22%46.14%4.20
Certara, Inc. (CERT)1.96%$2.86B5.57%47.35%8.07
10X Genomics, Inc. (TXG)1.93%$3.94B19.81%66.15%10.12
Regeneron Pharmaceuticals, Inc. (REGN)1.88%$103.89B7.76%82.89%6.99
Tango Therapeutics, Inc. (TNGX)1.83%$847.34M46.93%93.39%17.45
Kymera Therapeutics, Inc. (KYMR)1.72%$2.46B67.84%95.46%15.22
Alector, Inc. (ALEC)1.71%$576.41M-27.36%90.88%1.63
Verve Therapeutics, Inc. (VERV)1.71%$1.04B505.77%53.61%29.39
Ionis Pharmaceuticals, Inc. (IONS)1.71%$6.32B34.10%95.98%8.73
Exscientia Plc (EXAI)1.69%$721.40M-25.57%-114.12%14.32
Evotec SE (EVO)1.67%$2.77B21.97%19.27%4.39
4D Molecular Therapeutics, Inc. (FDMT)1.65%$1.59B562.29%72.26%25.06
Caribou Biosciences, Inc. (CRBU)1.45%$464.22M148.91%89.78%3.53
Century Therapeutics, Inc. (IPSC)1.44%$270.94M-57.01%-483.62%32.37
Compass Pathways Plc (CMPS)1.43%$515.37MN/AN/AN/A
Denali Therapeutics, Inc. (DNLI)1.39%$2.86B204.74%94.94%5.95
Roivant Sciences Ltd. (ROIV)1.36%$8.49B117.80%82.20%30.90
Editas Medicine, Inc. (EDIT)1.34%$607.06M296.32%92.24%6.18
Revolution Medicines, Inc. (RVMD)1.27%$5.31B-67.27%19.61%127.82
Olink Holding AB (OLK)1.25%$2.92B21.60%58.19%17.80
Arvinas, Inc. (ARVN)1.21%$2.81B-40.26%91.46%13.01
Intellia Therapeutics, Inc. (NTLA)1.19%$2.64B-30.40%75.26%52.65
Beam Therapeutics, Inc. (BEAM)1.05%$2.70B520.01%94.70%2.87
Lyell Immunopharma, Inc. (LYEL)1.00%$566.63M-99.85%-15,476.92%29.62
Ultragenyx Pharmaceutical, Inc. (RARE)0.92%$3.84B19.52%84.48%8.92
Ginkgo Bioworks Holdings, Inc. (DNA)0.91%$1.92B-47.36%56.73%10.26
Moderna, Inc. (MRNA)0.80%$40.80B-64.16%22.40%4.47
Vir Biotechnology, Inc. (VIR)0.75%$1.37B-94.67%74.22%-0.72
SAGE Therapeutics, Inc. (SAGE)0.70%$1.13B1,024.84%97.50%6.33
Relay Therapeutics, Inc. (RLAY)0.69%$1.09B1,749.82%79.37%25.56
ProKidney Corp. (DNAC)0.69%$101.06MN/AN/AN/A
AbCellera Biologics, Inc. (ABCL)0.68%$1.33B-92.17%18.75%24.76
Erasca, Inc. (ERAS)0.64%$312.08MN/AN/AN/A
BioNTech SE (BNTX)0.63%$21.93B-77.31%85.01%3.14
Alnylam Pharmaceuticals, Inc. (ALNY)0.60%$18.82B76.23%83.02%13.21
Seer, Inc. (California) (SEER)0.60%$115.38M3.38%9.54%-10.81
Prime Medicine, Inc. (PRME)0.50%$839.57MN/AN/AN/A
Adaptive Biotechnologies Corp. (ADPT)0.44%$465.75M-8.11%42.57%3.47
Seres Therapeutics, Inc. (MCRB)0.20%$116.90M1,672.24%88.04%2.10
Market data by FactSet